Roivant Sciences (ROIV) Receivables (2021 - 2024)

Roivant Sciences (ROIV) has 4 years of Receivables data on file, last reported at $678000.0 in Q4 2024.

• Quarterly Receivables fell 98.35% year-over-year to $678000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $678000.0 (down 98.35% YoY) and the FY2024 annual result came in at $678000.0, down 98.35% from the prior year.
• Receivables retreated to $678000.0 in Q4 2024, from $1.9 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $79.8 million in Q2 2024 to a low of $678000.0 in Q4 2024.
• A 4-year average of $22.5 million and a median of $11.2 million in 2021 frame the typical range for Receivables.
• Annual changes were most pronounced in 2023 — Receivables jumped 683.37% — and 2024, when it slumped 98.35%.
• Tracing ROIV's Receivables over 4 years: stood at $8.9 million in 2021, then surged by 213.5% to $28.0 million in 2022, then surged by 46.88% to $41.1 million in 2023, then tumbled by 98.35% to $678000.0 in 2024.
• The last three Receivables figures came in at $678000.0 (Q4 2024), $1.9 million (Q3 2024), and $79.8 million (Q2 2024), per Business Quant data.